Abstract
The colony formation assay (CFA) is a widely used method to assess the self-renewal capacity of cancer cells and evaluate how this property is affected by drug treatment. This protocol presents a streamlined, high-throughput CFA workflow optimized for T-cell acute lymphoblastic leukemia (T-ALL), making it suitable for large-scale drug screening projects. Colonies are grown in a methylcellulose-based 3D matrix and quantified using an automated analysis pipeline, allowing robust estimation of colony number and size. This cost-effective approach provides a scalable platform for identifying compounds that impair self-renewal, facilitating prioritization of hits for validation in more complex in vivo models.
| Original language | English |
|---|---|
| Article number | 103757 |
| Journal | Stem Cell Research |
| Volume | 87 |
| DOIs | |
| State | Published - Sep 2025 |
Bibliographical note
Publisher Copyright:© 2025 The Authors
Funding
This research was supported by the National Cancer Institute ( R37CA227656 to JSB) and the Kentucky Pediatric Cancer Research Trust Fund ( PON2 728 2400001524 to JSB).
| Funders | Funder number |
|---|---|
| National Childhood Cancer Registry – National Cancer Institute | R37CA227656 |
| Kentucky Pediatric Cancer Research Trust Fund | PON2 728 2400001524 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Colony formation assay
- Drug screening
- High-throughput
- Leukemia
- Self-renewal
ASJC Scopus subject areas
- General Medicine
- Developmental Biology
- Cell Biology
Fingerprint
Dive into the research topics of 'A high-throughput workflow for assessing self-renewal using colony formation assays'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver